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Background: The discovery of mesenchymal stem cells (MSCs) or MSC-like cells in cartilage tissue does not tie in
well with the established view that MSCs derive from a perivascular niche. The presence of MSCs may raise
concerns about specificity and application safety, particularly in terms of the regulatory site. The aim of the present
study was to investigate the benefits or possible risks of the MSC-like properties of cells isolated from cartilage in
the context of autologous chondrocyte implantation.
Methods: Chondrocytic cells were isolated from cartilage or intervertebral disc tissue. Flow cytometry was used to
analyze the expression of cell surface antigens. MSC-like cells were either enriched or depleted by means of
magnetic cell sorting (MACS) involving the monoclonal antibodies W5C5/SUSD2 and W8B2/MSCA-1. We addressed
the issues of prolonged expansion of such cells as well as the influence of culture medium as a trigger for selecting
a single cell type. Established protocols were used to study in vitro differentiation. In addition to histological and
biochemical assessment, the acquired phenotypes were also evaluated on the mRNA transcript level.
Results: In the studied cells, we found strongly analogous expression of antigens typically expressed on MSCs,
including CD49e, CD73, CD90, CD105, CD140b and CD166. The expression of W5C5 and W8B2 antigens in cartilage
cell sub-populations did not correlate with multi-potency. We demonstrated that a chondroid precursor, but not a
bona fide multipotent mesenchymal, cell type can be obtained under established in vitro culture conditions. The
culture media used for expansion influenced the cell phenotype.
Conclusions: The risk of adverse adipose or osseous differentiation is not posed by expanded chondrocyte
cultures, even after enrichment of putative MSC-like cell populations by MACS. It is possible that this limited
“stemness” in chondrocytes, expanded for use in ACI, may instead be beneficial as it allows re-differentiation under
appropriate conditions despite prolonged times in culture.
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DifferentiationIntroduction
Mesenchymal stem cells (MSCs), also referred to as mesen-
chymal stromal cells, are undifferentiated cells present in
various adult tissues. The multi-potent differentiation cap-
acity of human MSCs was first described by Pittenger et al.
at the turn of the 20th century [1]. MSCs represent a prom-
ising candidate cell population in regenerative medicine
and published reports of their application in numerous
cases demonstrate their therapeutic potential in the regen-
eration of all skeletal tissues, as well as of soft tissue organs.* Correspondence: benz@nmi.de
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reproduction in any medium, provided the orOne particular advantage of MSCs is that they can be used
when cells from the target tissue for regeneration are not
available for developing cellular therapy. This is the case in
intervertebral disc degeneration and MSC therapy repre-
sents a promising tool.
Cartilage and cartilaginous tissues are predominant in
regenerative medicine due to the fact that they comprise a
simple, homogenous tissue involving only one cell type,
the chondrocyte. Consequently, autologous chondrocyte
implantation (ACI) became an established cell-based med-
ical procedure for repairing cartilage defects, and, like
bone marrow transplantation, it obviously represents a key
technology in regenerative medicine. Recent reports haved. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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are present in cartilage and intervertebral disc tissue [2-8].
Evidently, cartilage contains not only functionally differen-
tiated cells (chondrocytes) but also undifferentiated pro-
genitors or stromal stem cells. This raises the question
about whether ACI should still be considered a chondro-
cyte implantation or whether it is more correctly a stem
cell therapy.
The discovery of MSC-like cells in cartilage tissue is
significant because it questions the prevailing view that
MSC isolated from bone marrow or any other organ or
tissue derived essentially from a perivascular niche [9-12].
The cellular component of the perivascular niche that
functions as a stem cell in the postnatal organism is the
pericyte [9,13]. Once this concept was established, a
search began for perivascular niches harboring MSCs
and published reports described such niches in several
tissues, including human brain tissue [14,15]. Articular
cartilage, however, is an avascular tissue devoid of blood
vessels (in healthy tissue), a fact that raises the question
about the cellular nature and function of MSC-like cells
within cartilaginous tissues.
The source of cells for ACI is cartilage [16] or, for disc
repair, is disc (prolapse) tissue [17], with the cells usually
being expanded in vitro and subsequently re-implanted.
Alterations in cell properties may occur during in vitro
manipulation. Expansion may favor particular cell types,
and, in terms of chondrocytes, this in vitro expansion
has historically been described as progressive, and at
least partly irreversible, de-differentiation and cellular
ageing [18,19]. Changes occur as early as in the first pas-
sage [20]. When incubated in three-dimensional con-
structs, cells may regain their chondrocytic phenotype
[21]. However, beyond a certain number of cell dou-
blings or passages, this phenotypic loss is apparently
irreversible [22,23]. Pelttari et al. showed that chondro-
cytes which underwent more than six population dou-
blings in vitro lost the capacity to form stable ectopic
cartilage [24].
On the other hand, this phenomenon may also be
described as the regression towards an undifferentiated
cell type with higher plasticity which, however, shows a
need for specific induction of the cartilage phenotype.
Up-regulation of markers regarded as distinctive for
MSCs (CD10, CD90, CD105, and CD166) on articular
chondrocytes monolayer cultures supports the theory of
a reversion to a primitive phenotype [25]. The existence
of chondrocyte subpopulations with phenotypic plasti-
city, that are capable of generating a chondrogenic, adi-
pogenic, and osteogenic lineage, has been reported by
several authors [8,26-29].
From a regulatory perspective, it is essential to clarify
these cell biological aspects of ACI, particularly in view
of future MSC applications in cartilage and disc repair.The aim of the present study was to evaluate the “stem
cell” features or “stemness” of chondrocytes populations
and identify whether they are advantageous or not
within the context of ACI.
To address this issue, the MSC sub-population hy-
pothesis was tested by means of selective enrichment or
depletion of cells presenting MSC antigens, using MACS
technology, from freshly-isolated primary cultured cells.
Subsequently prolonged expansion was done and an
analysis of the differentiation capacity followed each
stage. The influence of culture medium as a trigger for
selection towards a single cell type was also addressed.
MSC surface antigens as detected by monoclonal anti-
bodies (mAb) clone W5C5 (alias SUSD2, shushi domain
protein 2) or W8B2 (alias MSC antigen-1 (MSCA-1) or
tissue non-specific alkaline phosphatase (TNAP)),
known to correlate with specific phenotypic skeletal
characteristics, have been used to generate subpopula-
tions. It has been suggested that MSCA-1+/CD56+
MSCs are an attractive starting population for ACI be-
cause differentiation experiments had shown that chon-
drocytes were predominantly derived from this subset
[30]. However, the MSCA-1+ fraction of human jaw
periosteum-derived cells showed a significantly higher
osteogenic capacity than the negative fraction [31]. The
antigen recognized by the W5C5 antibody is SUSD2
(Sivasubramaniyan, et al.: Prospective isolation of
mesenchymal stem cells from human bone marrow
using novel antibodies directed against Sushi domain
containing protein 2 (SUSD2), submitted); the antibody
describes distinct MSC subpopulations and can be used
for the prospective isolation of highly-purified bone mar-
row MSCs [32]. Very recently, W5C5 epitope /SUSD2
was identified as a single marker capable of purifying
endometrial MSCs, possessing MSC properties and re-
constituting endometrial tissue in vitro [33].
We, therefore, investigated whether the selection of
cartilage-derived cells by MSC-specific mAbs yielded a
chondroid precursor cell type or multi-potent MSC-like
cells. We hypothesized that the results would provide
evidence about whether in vitro expanded chondrocyte
cultures are associated with a risk of adverse adipose or
osseous differentiation or not, especially after enrich-
ment of putative MSC-like cell populations.
Materials and methods
Articular chondrocyte and intervertebral disc cell isolation
and culture
Cell isolation and culture were performed as described
in [34,35].
Briefly, macroscopically normal appearing cartilage
was carefully harvested from the tibial plateau and from
the condyles. Tissue samples were washed in phosphate
buffered saline (PBS; BioWhittaker; Verviers, Belgium)
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degraded overnight using collagenase B (Roche; Mannheim,
Germany) and hyaluronidase (Serva; Heidelberg, Germany).
Isolated cells were filtered through a cell strainer and after
centrifugation the cells were resuspended and used for
MACS separation (see below) or expanded in primary
culture. To this end, 0.5 x 106 cells were plated in a 75 cm2
cell culture flask in DMEM/Ham’s F12 (Lonza; Cologne,
Germany) chondrocyte culture medium (CM) supple-
mented with 10% FCS or human AB serum (HS; IKET;
UKT, Tuebingen, Germany) as indicated, 150 μM ascorbic
acid-2-phosphate (Sigma-Aldrich; Munich, Germany),
100 U/ml penicillin, 100 μg/ml streptomycin (PAA; Pasching,
Austria). The culture was kept at 37°C in humidified atmos-
phere and 5% CO2. The cells were harvested at 80 - 90%
confluence by trypsin-EDTA (Lonza; Cologne, Germany)
treatment. The harvested cells (“P0 cells”) were used for
MACS separation. All human tissues were obtained from
the BG Trauma Center in Tuebingen (approved by the
local ethics committee and informed consent from all
individuals). Details for donors and cell culture condi-
tions are summarized in Additional file 1: Table S1.
Cell surface antigen profile
To investigate if chondrocytes and disc cells express typ-
ical MSC surface markers flow cytometry was per-
formed. Therefore phenotype profiling was performed
with P0 cells. The cells were detached, washed, incu-
bated on ice with phycoerythrin (PE)-conjugated mono-
clonal antibodies directed against CD34, CD45, CD49e,
CD73, CD90, CD105, CD140b, CD166, CD271, W8B2
(MSCA-1), W5C5 (SUSD2), according manufacturer’s
instructions (for further information see Additional file
1: Table S2) and analyzed by flow cytometry (Cytomix
FC500; Beckman Coulter; Krefeld, Germany). Addition-
ally for comparison with P0 profiles, surface antigen pro-
files of chondrocyte subpopulations after expansion > 8
population doublings (pds) were performed using the
same protocol.
Enrichment of cells using W5C5- and W8B2-coupled
magnetic microbeads
W5C5+ and W8B2+ cell populations were enriched by
magnetic separation using the MACSW technology. The
magnetic labeling and the magnetic separation were
performed according to the supplyers protocol # 130-
093-583 for the anti-MSCA-1 (W8B2, Microbead Kit,
Miltenyi Biotech, Bergisch Gladbach, Germany). Briefly,
human chondrocytes or human disc cells directly after
enzymatic digestion or from first passage (P0) were
attached to anti-W5C5 or anti-W8B2 microbeads, re-
spectively, for 15 min. at 4°C. Magnetic separation
resulted in three cell populations: the unsorted whole
cells (unsorted), the positively enriched population(pos. +) and the depleted (neg. -) fraction. To analyze
the quality of the separation flow cytometry (see above)
based on the same antibodies was performed after
MACS separation.
Gene expression analysis
The gene expression analysis was performed in parts
according to MIQE guidelines [36]. Total RNA was
extracted using the RNeasy mini kit plus DNase I diges-
tion according to the manufacturer’s instructions (Qiagen;
Hilden, Germany). RNA purity was determined by photo-
metric measurement of the 260 nm/280 nm ratio of the
sample using a Bio Photometer (Eppendorf #613125116,
Hamburg, Germany). Complementary DNA (cDNA) was
obtained by reverse transcription of up to 1 μg total RNA
using the Reverse Transcriptase Core kit (Eurogentec;
Cologne, Germany) with EuroScript reverse transcript-
ase (Moloney Murine leukemia virus rev. transcriptase,
50 U/μl) and oligo-dT primers. Reverse transcription was
performed in a total volume of 50 μl at 48°C for 30 min. in
a thermocycler (Whatman Biometra; Goettingen, Germany).
Gene expression was analyzed by semi-quantitative real-
time PCR using an Applied Biosystems 7500 Fast Real-
Time PCR System as described in [34]. The qPCR master-
mix plus for SYBR green I (low ROX) kit from Eurogentec
was used. Primers were designed with the primer express
2.0 software (Applied Biosciences; Darmstadt, Germany),
except primers for type II collagen (Col2A1) [37], and
were obtained from BIOTEZ. Sequences of all primers
used are summarized in Additional file 1: Table S3.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
used as reference gene. Quantification cycles (Cq values)
were determined for each gene using Sequence Detection
System software (Applied Biosystems) [38]. PCR efficiencies
(E) were calculated for each primer pair using a calibration
curve. Relative gene expression was calculated according to
the following equation:
relative mRNA expression ¼ E
Cq reference geneð Þ
ECq marker geneð Þ
:
Analysis of the chondrogenic state of differentiation after
sorting
Five x 105 cells were embedded into 500 μl human
serum albumin – hyaluronan (HSA-HA) hydrogel dir-
ectly after the MACS separation. HSA-HA preparation
and cell embedding in hydrogels are described in [34].
The gels were overlaid with either 1.5 ml chondrocyte
culture medium (CM) or chondrogenic induction medium
(DMEM high glucose, 4.5 g/l (Invitrogen), 100 U/ml peni-
cillin, 100 μg/ml streptomycin, 4 mM L-glutamine, 1 mM
sodium-pyruvate, 170 μM ascorbic acid 2-phosphate,
0.1 μM dexamethasone, 1 × ITS supplement, 0.35 mM L-
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(Miltenyi Biotech) and cultured for six weeks. Medium
was changed twice a week for a total culture time of six
weeks. Cell culture supernatants were collected for bio-
chemical analysis. Subsequently, the gels were either fro-
zen for biochemical analysis, or digested with proteinase K
(3 mg/ml; Sigma-Aldrich) for about 15 min. at 37°C to
recover the cells for gene expression analysis. The digest
was centrifuged and the cell pellet lysed in 350 μl lysis
buffer (RLT-buffer, Qiagen; Hilden, Germany).
Biochemical analysis
To analyze the extracellular matrix production the glyco-
saminoglycan (GAG) content was determined in the
digested hydrogels and in the supernatants. Hydrogels
were digested with 1 mg/ml papain (Sigma-Aldrich) in
0.1 M Na-acetate, 0.01 M L-cysteine, 0.05 M Na2-EDTA,
and 0.2 M NaCl (pH 6.0) at 60°C overnight and stored at
−80°C. Culture supernatants were used without digestion.
Supernatants were freeze-dried and stored at −80°C. For
measurement the supernatants were re-constituted with
H20 and thereby concentrated by a factor of 5. The GAG
content was measured by the dimethylmethyleneblue (DMB)
assay, including guanidinium hydrochloride in the proto-
col and using chondroitin-4-sulfate (Sigma-Aldrich) as a
standard [39]. Proteoglycan content was normalized to
DNA content and expressed as μg GAG/ μg DNA. The
DNA content in the hydrogels was determined using the
PicoGreen fluorescent dye (Molecular Probes/Invitrogen).
Standard curves were generated at the time of each meas-
urement using known concentrations of phage lambda
DNA (Eppendorf; Hamburg, Germany). DNA content was
expressed as μg DNA.
Analysis of replicative capacity - cell growth curves
Cells were plated at a starting cell density (6.7 x 103
cells/cm2), cultivated to reach confluence (80 – 90%),
and harvested using trypsin/EDTA. The cell number was
determined. The number of population doublings (pds)
was calculated using the following equation: log (cell
number at harvest/seeding cell number)/log2. A cell ali-
quot was used for gene expression analysis. Cells were
expanded for several passages under identical conditions
until they underwent at least 8 to 10 pds after MACS
separation. Then the cells were used for differentiation
experiments. Two cultures were additionally expanded
in mesenchymal stem cell growth medium (MSCGM,
Promocell; Heidelberg, Germany) to test the influence of
the medium. These cultures are marked in the results by
the suffix “MSCGM” to the culture number.
Growth curves were calculated as a function of popu-
lation doublings over the cultivation time. To describe
changes in the cellular phenotype dependent from the
population doublings, the expression of collagen type Iα2 (COL1a2), collagen type II α21 (COL2a1), SRY (sex
determining region Y)-box 9 (SOX9), and core-binding
factor subunit alpha-1 (CBFA1, also known as Runt-
related transcription factor 2 (RUNX2)) was analyzed
directly after MACS, after 4 +/− 1 pds, and after > 8 pds.
In vitro differentiation protocols and related read-out
assays
To analyze the differentiation potential, cells were
induced to differentiate in the adipogenic, osteogenic
and chondrogenic lineage.
Adipogenic induction
For adipogenic induction a commercially available adi-
pogenic differentiation medium was used (Promocell #
C-28011) and the differentiation performed according
to the manufacturer’s instructions. Briefly, 3.15 x 104
cells/cm2 were plated in a tissue culture plate using MSC
Growth Medium. Cells were allowed to reach 80 – 90%
confluence, and then the medium was exchanged for MSC
adipogenic differentiation medium. Controls were main-
tained in MSC growth medium. After induction the cells
were cultured for three weeks, medium was changed twice
a week. At the end of the culture period cells cultured
in 24-well plates for gene expression analysis were lysed
directly with 500 μl lysis buffer per well (RLT buffer,
Quiagen; Hilden, Germany). Cells cultured in 96-well
plates were used for Oilred O staining and were pro-
cessed as described below.
Gene expression
The induction of adipogenic specific genes, Peroxisome
proliferator-activated receptor gamma (PPARγ2) and
adiponectin, was analyzed by semi-quantitative real-time
PCR in cell cultures after adipogenic induction and com-
pared to controls.
Oil red O staining
To localize lipid droplets, cell layers were fixed in 4%
paraformaldehyde, incubated in 60% n-propanol, and
then stained in Oil Red O solution for 10 minutes. Cells
were washed and cell nuclei counterstained with Mayers
haemalaun solution for 3–5 minutes. Cell layers were
rinsed with tap water to develop the blue nuclei staining
and then microscopically observed.
Osteogenic induction
For osteogenic induction a commercially available osteo-
genic differentiation medium was used (Promocell # C-
28013) and the differentiation performed according to
the manufacturer’s instructions and as described under
“adipogenic induction” with the exception that cells were
allowed to reach > 100% confluence before the medium
was exchanged for osteogenic differentiation medium.
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mination of alkaline phosphatase (ALP) activity and Ali-
zarin Red staining and were processed as described
below.Gene expression
The induction of osteogenic specific genes, CBFA1 and
ALP, was analyzed as described above.Quantitative assay of ALP activity
ALP activity was determined using p-nitrophenyl phos-
phate as substrate. Cell cultures (triplicates in 96-well
plates) were washed and incubated with 100 μl 0.01%
Triton X-100 for 30 min. at 4°C. 50 μl of the lysate was
transferred into another 96-well plate and mixed with
50 μl of 0.01% Triton X-100. Then 200 μl p-nitrophenyl
phosphate were added per well and the plate was incu-
bated for ≥ 30 min. at RT. The absorbance at 405 nm
was measured using a Pherastar plate reader (BMG Labtech,
Offenburg, Germany). Serial dilutions of p-nitrophenol were
used for the standard curve. The ALP activity was expressed
as substrate conversion per time [pmol/min.] and was nor-
malized to the DNA content [μg] of the corresponding well.Alizarin red staining
To identify mineral deposits by Alizarin Red S, the cell
monolayers were washed and fixed with ice-cold 50%
methanol, 50% acetone and were then air dried. After
washing the cells were stained with 40 mM Alizarin Red
S (pH 4.0) for 20 minutes. After extensive washing the
cell layer was dehydrated with ice-cold 100% ethanol
and air-dried before microscopically examination.Chondrogenic induction
Chondrogenic differentiation potential of the cells was
analyzed in HSA-HA hydrogels. HSA-HA preparation
and cell embedding into hydrogels are described in [34].
Five x 105 cells were embedded into 500 μl hydrogel.
After a few minutes of polymerization the gels were cul-
tured in 1.5 ml chondrogenic induction medium (see
above). Controls were cultured in the same medium
without TGF-β3. Hydrogels were cultured for four
weeks; medium was changed twice a week. Cell culture
supernatants were collected for biochemical analysis.
After four weeks the gels were frozen for biochemical
analysis and digested with proteinase K to recover the
cells for gene expression analysis respectively.Gene expression
The induction of chondrogenic specific genes SOX9, COL2a1,
and aggrecan (ACAN) was analyzed as described above.Statistics
Gene expression data were used as logarithmic values to
obtain data which follow Gaussian distribution.
Statistical analysis was not necessary for differentiation
of chondrocytes (Figure 1), cell surface antigen expression
(Figure 2), and cell growth and morpholgy (Figure 3). For
results presented in Figure 4: One Way Analysis of Vari-
ance (ANOVA) was performed if data passed normality
test (Tukey-Kramer Multiple Comparisons Tests). If data
did not pass the normality test nonparametric ANOVA
was performed (Kruskal-Wallis Test). For results pre-
sented in Figures 5, 6, 7 and 8: Two hypotheses were
tested in the differentiation assays: 1) “There is a signifi-
cant difference between control and induction condi-
tions”. To confirm the first hypothesis an unpaired t-test
comparing all control samples with all induced samples
was performed. When data did not pass the normality
test, a Mann–Whitney test was used. 2) “There are differ-
ences between the subpopulations/subgroups under the
same experimental conditions”. To confirm the second
hypothesis two ANOVAs were performed comparing un-
sorted, W5C5+ and W5C5- populations either under con-
trol or under induction conditions.
Due to the small number of W8B2 +/− samples, they
were excluded from statistical analysis. In “Results”, the
use of the term “significant” relates to a p < 0.05 level of
significance.
Results
Feasibility of MACS sorting of freshly isolated or pre-
cultured primary chondrocytes and disc cells
To prove the feasibility of the MACS technique of chon-
drocytes and disc cells, directly from tissue digests or after
expansion in primary culture, an experimental set-up was
installed as described below (Additional file 2: Figure S1).
Cartilage or disc tissue was enzymatically digested and the
isolated cells either used directly for MACS sorting or
seeded into a primary culture. The primary cells were
expanded until they reached 80 – 90% confluency and
were then analyzed by MACS. The obtained sub-
populations were tested in a three-dimensional hydrogel
which is already being used clinically (www.clinical-
trials.gov; identifier:NCT01640457).
MACS with freshly isolated chondrocytes
In the first set of experiments, the magnetic separation
of freshly-isolated chondrocytes after overnight enzym-
atic digestion was examined. As the MACS technology
is available for clinical use, it is important to clarify
whether the cell sorting process could be embedded into
a clinical set-up, i.e. as a one-step operating procedure.
All attempts to separate freshly-isolated cells by MACS
have not been successful: the separation columns clogged
after the cell suspension was applied to the separation
Figure 1 Differentiation of chondrocytes and sorted sub-populations. Expression of mRNA in primary expanded human chondroyctes after
MACS separation (P0), and subsequent passage in monolayer (P1 ML) or in hydrogel culture (P1 Gel). The P1 ML cells were cultured in
chondrocyte medium (CM) until they had reached approx. 80% confluence (about 1 week), hydrogels were maintained in CM for 6 weeks. The
expression of collagen type I (COL1), type II (COL2), and aggrecan (ACAN) was analyzed and the ratio of COL2/COL1 was calculated as a measure
to describe the chondrogenic phenotype of the cells as indicated. Box plots represent 25% / 75% percentiles, mean values (dotted lines) and
median values (hairlines). Lower right: the cumulated glycosaminoglycan production from cells in hydrogel culture was determined. GAG content
was measured in the hydrogel and in the combined medium supernatant of the six-week cultures and normalized to the corresponding DNA
content in the hydrogel. Mean values and standard deviation are shown (n = 3 cultures).
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washing steps. Instead, the cells had to be pushed out by
means of a plunger and then layered on to a new column.
Following this, it was occasionally possible to proceed suc-
cessfully and to carry out the separation. The recovery rate
was only about 40% and the percentage of positive cells was
below 10% of all cells. In the majority of cases, however,
successful separation could not be achieved. Therefore, the
magnetic separation of freshly-isolated chondrocytes was
not considered to be a reliable and efficient method.
MACS with primary expanded chondrocytes / disc cells
Consequently, the magnetic separation was carried out
using cells from primary expanded cultures. The resultsof the recovery, efficiency and quality of the separation
are summarized in Table 1.
With primary chondrocytes and primary disc cells
MACS sorting using W5C5 and W8B2 microbeads was
feasible and led to satisfying results. On average, approx.
60% of the cells initially used could be recovered. The
percentage of W5C5 positive cells was 20.2% ± 8.0 for
chondrocytes and 13.3% ± 3.9 for disc cells. After W8B2
sorting, only 5.8% ± 1.7 positive chondrocytes were
obtained: in other words, on average, only 0.8 x 106 cells
were in the bound fraction (positive fraction) of a typical
cell preparation. However sufficient cell numbers were
not obtained and therefore re-differentiation of W8B2
cells in hydrogels was not pursued. Only W5C5-
Figure 2 Cell surface antigen expression of selected markers on cartilage cell populations. Human chondrocytes (P0), and human disc
cells (P0) were stained with the indicated phycoerythrin-conjugated monoclonal antibodies. The black lines show the fluorescence intensity of
the IgG negative control antibody, whereas the intensity of the antibody of interest is shown in red. Representative analyses are shown.
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lyzed further.
The efficacy of separation by MACS varied considerably.
In the W5C5+ fractions, about 88% of the cells were posi-
tive for W5C5 as determined by flow cytometry, but the
W5C5- fraction still contained more than 1/3 positive
cells. The W8B2+ fraction was even less pure, and only
about 78% of the cells were positive when investigated by
flow cytometry; with the depleted fraction contained about
18% positive cells. After MACS sorting, the cell cultures
showed a high viability and cell attachment was not
impaired by the magnetic labeling (data not shown).
Analysis of the chondrogenic state of differentiation after
sorting
To analyze whether the chondrogenic phenotype and
differentiation state correlated with the presentation of
the W5C5 antigen on chondrocytes, the gene expression
of collagen type I and type II, and of aggrecan in cells
was analyzed directly after MACS separation (P0), and
in passage 1 cells cultured in monolayer or in three-
dimensional hydrogel culture (Figure 1). To describe dif-
ferentiation, the ratio of collagen type II / collagen type I
was calculated. Collagen type I and aggrecan were very
stably expressed at high levels in all sub-populations, re-
gardless of the monolayer or hydrogel culture. In con-
trast, collagen type II expression decreased in the P1
monolayer cells (P1 ML) as compared to P0 cells, but
the expression increased in the parallel hydrogel culture.In other words, the three-dimensional environment in
the hydrogel culture was able to stabilise, and possibly
even slightly improve, the chondrogenic phenotype. The
COL2 / COL1 ratio of the hydrogel cultures was about
20 times higher than in P1 ML cells. The result was the
same for all three sorted cell populations (Figure 1).
To further describe the quality of the hydrogel cultures,
the amount of synthesised glycosaminoglycans was deter-
mined using a DMB assay. We did not find meaningful
differences in the GAG content, either within the hydro-
gels nor when released into the supernatant during the six
weeks of culture (Figure 1, lower right). The unsorted
chondrocyte population, as well as the W5C5+ and
W5C5- fractions had a cumulative GAG production of
about 6 μg GAG per μg DNA, and GAGs were mostly
secreted into the culture medium (on average > 85%). The
cells synthesized about 1 μg GAG per μg DNA per week.
MSC surface antigen presentation on chondrocytes and
disc cells
The presence of cells displaying some of the typical
MSC antigens in cartilage tissue has been already shown
[29,40]. Therefore, investigations focused on the MSC
surface marker antigens that were also present on our
chondrocytes and disc cell populations. The expression
of CD34, CD45, CD49e, CD73, CD90, CD105, CD140b,
CD166, CD271, W5C5, and W8B2 was analyzed (Figure 2).
Cultured chondrocytes as well as disc cells (P0), have
been shown to share common surface antigens with
Figure 3 Cell growth and morphology of chondrocytes and sub-populations. A) Unsorted chondrocytes and W5C5 or W8B2 enriched (+) or
depleted (−) sub-populations of the same culture (Cho4) were expanded over several passages. Population doublings and culture time are
presented (top). Chondrocytes (Cho8) and W5C5 ± sub-populations are cultured in chondrocyte culture medium (CM) or MSC growth medium
(MSCGM). Growth curves are shown (bottom). B) Cell morphology of different sub-populations. (Due to the low expression of W8B2 on
chondrocytes, the number of sorted cells was too low for a complete set of experiments).
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CD73, CD90, CD105, CD140b, and CD166. Lower ex-
pression of W5C5 and W8B2 was found, although a few
chondrocytes displayed high intensity (Figure 2; see also
Table 1). The cells are negative for CD34 and CD45; this
is by definition also a required feature for MSC. As
reported for MSC in culture [30,32], CD271 is not
expressed on cultured chondrocytes and disc cells.
Analysis of MSC characteristics of W5C5 and W8B2
positive sub-populations
To investigate whether W5C5 or W8B2 sub-populations
isolated from chondrocyte or disc cell cultures show
MSC characteristics, their replicative capacity anddifferentiation potential were analyzed based on the fol-
lowing experimental set-up (Additional file 2: Figure S2).
Analysis of the replicative capacity of chondrocytic sub-
populations dependent on the W5C5 or W8B2 antigen
presentation
To investigate whether the expression of W5C5 or W8B2
was related to the replicative properties of cell sub-popula-
tions, MACS-separated cell populations were cultured over
several passages until they had undergone more than 8 pds
and growth curves were calculated. The cell morphology
during culture was photo-documented.
Table 2 shows the average culture time necessary to
obtain about ten population doublings for the cultures.
Figure 4 Gene expression of chondrocytic sub-populations dependent on the population doublings. Primary expanded chondrocytes and
disc cells were MACS separated and expanded in monolayer cultures over several passages. Gene expression was determined at the end of the
first passage after MACS sorting (MACS P0), when cells had undergone 4 ± 1 pds after MACS, and after cells had undergone more than 8 pds
after MACS. Expression of collagen type I (COL1), collagen type II (COL2), and the transcription factors SRY (sex determining region Y)-box 9
(SOX9) and core-binding factor subunit alpha-1 (CBFA1) were analyzed and expressed relative to the reference gene GAPDH. *: significant
difference (p < 0.05) between all chondrocyte populations compared to all disc populations. (For mean expression values see Additional file 1:
Table S4).
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age approx. 9.5 pds. They grew at an average growth rate of
0.16 pds/d. The growth rate was relatively constant during
the passages, but, for some cultures, growth slowed down
during the last passage (Figure 3A). Only minor differenceswere observed between the different sub-populations and
the unsorted whole cell population. In addition, no mor-
phological differences could be seen (Figure 3B). Chondro-
cytes that were grown in MSC growth medium (MSCGM)
were able to divide much faster, and the pds/d increased to
Figure 5 Adipogenic differentiation of sub-populations after > 8 pds. Adipogenic differentiation was induced using adipogenic induction
medium, control cells were cultured in MSC growth medium (MSCGM). Three weeks after induction gene expression of the adipogenic markers,
the transcription factor peroxisome proliferator-activated receptor γ 2 (PPARγ2) and adiponectin was analyzed. Expression relative to GAPDH is
presented for each individual culture (left). In parallel, lipid droplets were visualized by Oil Red O staining (bars = 200 μm). Representative pictures
of one culture after induction are shown. Only very sporadically were positive cells found (pictures with higher magnification on the right). None
of the control cultures was positive. *: significant difference (p < 0.05) between all control cultures compared to all cultures under induction
conditions. (For mean expression values see Additional file 1: Table S5).
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chondrocytes, disc cells grew about 2.6-fold faster (keeping
in mind that disc cells were maintained in medium+HS
and chondrocytes in either FCS or HS).
To investigate whether phenotypic alterations or any
spontaneous differentiation had occurred during culture,
the gene expression of collagen type I and II and of the
two transcription factors SOX9 and CBFA1 was analyzed.
We originally did not intend to differentiate between
chondrocytes and disc cells; however, as their behavior
was significantly different, we have depicted the resultsfor the respective cell type (Figure 4). The expansion of
chondrocytes in MSCGM altered the gene expression
(see Additional file 1: Table S4). As only minor differ-
ences were observed between the mAb enriched sub-
populations, we combined all sub-populations for statis-
tical analyses and compared the three groups
“chondrocytes”, “disc cells”, and “chondrocytes MSCGM”
using ANOVA (data for MSCGM were not shown in
Figure 4, only in Additional file 1: Table S4). However,
W8B2 +/− sub-populations were excluded from the statis-
tical analysis due to the small sample size.
Figure 6 Osteogenic differentiation of sub-populations after > 8 pds. Osteogenic differentiation was induced using osteogenic induction
medium, control cells were cultured in MSC growth medium (MSCGM). Three weeks after induction gene expression of the osteogenic markers,
the transcription factor core-binding factor subunit alpha-1 (CBFA1) and alkaline phosphatase (ALP) were analyzed. Expression relative to GAPDH
is presented for each individual culture (top). ALP activity was determined in the cell lysates at the end of the culture and was normalized to the
corresponding DNA content in the well. In parallel, mineralization was visualized by Alizarin Red staining (bar = 200 μm). Representative pictures
of four induced cultures are shown. None of the control cultures was positive. *: significant difference (p < 0.05) between all control cultures
compared to all cultures under induction conditions. (For mean expression values see Additional file 1: Table S6).
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type I and SOX9 in chondrocytes and disc cells was
observed (Figure 4). These genes were expressed at com-
parable levels, regardless of the population doublings the
cells had undergone. Collagen type I expression varied
only in the range of one decade, SOX9 actually only by afactor of 4. COL1 expression was slightly but sig-
nificantly (p < 0.05) higher in disc cells compared to
chondrocytes in P0 after MACS and, in cells cultured
for additional 4 pds. SOX9 expression was significantly
lower in PO discs cells after MACS. Collagen type II
expression also differed significantly in PO cells.
Figure 7 Chondrogenic differentiation of sub-populations after > 8 pds. Chondrogenic differentiation was performed in hydrogels and
induced with TGFβ3, control cells were cultured in hydrogels in the same medium without TGFβ3. Four weeks after induction gene expression of
the chondrogenic markers, the transcription factor SRY (sex determining region Y)-box 9 (SOX9), collagen type II (COL2) was analyzed and
compared to the expression of the cells before being embedded into the hydrogels (ML > 8pds). Expression relative to GAPDH is shown for each
individual culture (top). Quantification cycles (Cq) for GAPDH expression are shown in the box plot. GAG synthesis (GAG content of the hydrogel
+ content in the cumulated culture supernatants) is presented as normalized to the DNA content (lower right). Boxes represent 25% / 75%
percentiles, whisker 5% / 95% percentiles, mean (dotted line) and median (solid line) values. *: significant difference (p < 0.05) between all ML > 8
pds cultures compared to all gel control cultures and compared to gel cultures under induction conditions. (For mean expression values see
Additional file 1: Tables S7 and S8).
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pared to disc cells. In chondrocytes, the collagen type II
expression decreased with increasing pds, but remained
more or less constant in disc cells. These results demon-
strate once again that the progressive de-differentiation
process of chondrocytes results in a lower ratio of colla-
gen type II to collagen type I. It also shows that, with in-
creasing pds, the cells became increasingly homogenous.In contrast, disc cells remained phenotypically more
stable.
CBFA1 expression in disc cell was significantly higher
than in chondrocytes, regardless of the stage of the expan-
sion process. Disc cells showed an almost constant mean
expression ranging from 2.39 to 2.49 x 10-4 relative to
GAPDH independent from the expansion state. In chon-
drocytes the CBFA1 expression increased slightly, from a
Figure 8 Comparison of chondrocyte sub-populations as a function of population doublings. Cells were analyzed at the end of the first
passage after MACS and subsequent expansion until cells had undergone more than 8 population doublings (pds). A) Flow cytometry analysis
with percentage of W5C5 positive cells after W5C5 MACS sorting and W8B2 positive cells after W8B2 MACS sorting. Representative examples are
shown. B) Adipogenic differentiation of subpopulations. Adiponectin expression relative to GAPDH. C) Osteogenic differentiation. ALP gene
expression relative to GAPDH and ALP enzyme activity were presented. Boxes represent 25% / 75% percentiles, whisker 5% / 95% percentiles,
mean (dotted line) and median (solid line) values. (n = 3 donors after MACS, n = 4 donors + > 8pds). *: significant differences (p < 0.05) between
cells differentiated directly after MACS and after expansion, and between subpopulations under the same experimental conditions. Significant
differences existed in all cases between the control and the induction conditions (not specifically indicated).
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they underwent additional > 8 pds.
In terms of the presentation of W5C5 or W8B2 anti-
gens, we found no obvious changes, neither for the repli-
cative capacity, nor for gene expression (See Additional
file 1: Table S4).
Analysis of the differentiation capacity of chondrocytic
subpopulations depending on W5C5 or W8B2 antigen
presentation
Because MSCs maintain their differentiation capacity for
several population doublings in vitro whereas differen-
tiated chondrocytes lose their re-differentiation potential
after only a few population doublings [22-24], we usedcells for the differentiation assays which had undergone
at least 8 pds to create most stringent conditions for
detecting true MSCs in the chondrocytic cell types. Adi-
pogenic, osteogenic and chondrogenic differentiation
was induced using standard protocols and media. Data
of the gene expression analysis are presented as scatter
plots for each culture in order to be able to single out
conspicuous cultures. There was no difference in the
cellular differentiation patterns in cells obtained by the
two baseline conditions with HS and FCS despite mod-
est differences in proliferation rates and phenotypic
alterations during expansion. Therefore, the two stand-
ard conditions were kept together and only discrimi-
nated against MSCGM.
Table 1 MACS technical data from primary expanded chondrocytes or disc cells (“P0 cells”)
W5C5 sorting



















Cho2 8.9 1.6 4.5 68.0 18.0 n.d. n.d. n.d.
Cho4 16.2 4.0 5.0 55.7 24.8 95.9 53.8 55.2
Cho5 8.8 2.2 4.7 78.4 24.5 86.6 47.8 74.7
Cho6 10.0 3.2 4.3 75.0 32.0 87.4 26.2 51.2
Cho7 37.2 4.8 30.5 94.9 12.9 75.4 12.0 24.9
Cho8 8.8 1.3 3.3 52.2 14.9 90.6 28.0 42.8
Cho9 12.8 2.9 6.2 71.1 22.7 78.5 24.9 41.7
Cho10 24.1 6.8 9.2 66.3 28.1 92.8 38.4 63.0
Cho11 13.1 2.0 6.5 64.7 14.9 94.5 30.1 43.7
Cho12 8.4 0.5 4.7 62.1 6.0 70.2 37.4 31.1
Cho13 19.3 4.4 8.7 68.0 22.7 97.0 52.7 74.6
Cho14 21.9 6.7 5.5 55.7 30.6 97.2 69.2 89.3
Cho15 9.0 0.9 3.7 51.4 10.4 95.1 32.2 42.2
mean 15.3 3.2 7.4 66.4 20.2 88.4 37.7 52.9
sd 8.5 2.1 7.2 12.0 8.0 9.1 15.7 19.2
disc cells
Disc1 n.d. 0.6 6.4 n.d. n.d. n.d. n.d. n.d.
Disc2 7.6 1.2 1.6 37.0 16.1 n.d. n.d. n.d.
Disc3 13.7 1.5 4.9 46.3 10.6 98.1 45.1 49.4
mean 10.7 1.1 4.3 41.6 13.3 98.1 45.1 49.4
sd 4.3 0.4 2.5 6.6 3.9
W8B2 sorting



















Cho3 9.5 0.6 5.8 67.3 5.8 n.d. n.d. n.d.
Cho4 16.2 0.7 7.2 48.5 4.3 72.8 8.7 5.6
Cho5 8.8 0.7 6.3 79.4 8.2 63.0 11.9 16.8
Cho14 22.4 1.1 7.3 37.4 4.8 98.8 34.5 50.4
mean 14.2 0.8 6.6 58.1 5.8 78.2 18.4 24.3
sd 6.4 0.2 0.7 18.8 1.7 18.5 14.1 23.3
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To determine the adipogenic differentiation potential of
chondrocytic sub-populations, gene expression of the
transcription factor peroxisome proliferator-activated re-
ceptor γ 2 (PPARγ2) and adiponectin, a peptide hor-
mone exclusively produced in adipose tissue, was
analyzed three weeks after induction (Figure 5). Oil RedO staining was used to visualise lipid droplets within the
cultures, this being the phenotypic signature of fat cells.
Under control conditions, PPARγ2 is expressed in all
sub-populations at a similar level (about 1 x 10-3 relative
to GAPDH), and adiponectin expression is very low, i.e.
almost at the detection limit of the RT-PCR (Figure 5).
After adipogenic induction, PPARγ2 was slightly, but
Table 2 Culture time, population doublings (pds), and growth rate of chondrocytic subpopulation after MACS
separation
W5C5 sorting
Cell type / Mean no. of Mean Population doublings (pds) /day
medium culture time passages pds Unsorted W5C5+ W5C5-
[d] Mean sd Mean sd Mean sd
chondrocytes 63.50 4 - 6 9.47 0.16 0.04 0.15 0.04 0.16 0.04
n = 4
chondrocytes 24.50 4 11.53 0.51 0.07 0.49 0.05 0.48 0.04
MSCGM; n = 2
disc cells 25.67 4 11.44 0.42 0.13 0.47 0.12 0.47 0.14
n = 3
W8B2 sorting
Cell type / Mean no. of Mean population doublings (pds) /day
medium culture time passages pds Unsorted W8B2+ W8B2-
[d] mean sd mean sd mean sd
chondrocytes 70.00 4 - 6 10.57 0.15 0.01 0.14 0.01 0.15 0.01
n = 3
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minor differences could be seen between the sub-popu-
lations. At the same time, adiponectin expression was
induced for most of the cultures about 100- to 500-fold.
This difference in comparison to the control cultures
was significant. Cho5 culture and disc cell culture no. 2
showed alternating behaviour and were not induced in
all cases. Under induction, W5C5+ showed lower adipo-
nectin expression than W5C5-, and W8B2- lower than
W8B2+; however, the effects were not significant. No
significant differences could be detected between the
subpopulations, neither under control nor under induc-
tion conditions. The rise in adiponectin mRNA expres-
sion did not correlate with the Oil Red O staining. Only
very rare, sporadically positive cells could be found
under induced conditions (Figure 5). In none of the
control cultures were lipid droplets found. No obvious
differences could be detected between disc cells and
chondrocytes expanded in MSC growth medium as
compared to standard chondrocyte cultures. Again, cul-
tures in MSC growth medium were propagated to ex-
clude negative selection of putative present stem cells
by the medium. (For further information, see Additional
file 1: Table S5.)
Osteogenic differentiation
To determine the osteogenic differentiation potential of
chondrocytic sub-populations gene expression of the tran-
scription factor CBFA1 (RUNX2) and alkaline phosphat-
ase were analyzed three weeks after induction (Figure 6).
On the protein level, ALP activity was measured and
mineralization of the cultures was detected by AlizarinRed staining. At first, the gene expression data of the
osteogenic marker genes appeared to be more heteroge-
neous than their adipogenic counterparts. CBFA expres-
sion was between 7 x 10-6 and 2 x10-4 and ALP expression
between 7 x 10-7 and 1 x10-6 (neglecting the outlier disc3
W5C5-). At the endpoint of the experiment, CBFA1 and
ALP expression of control cultures was significantly dif-
ferent to cultures under induction conditions. ANOVA
analysis revealed no differences between the individual
sub-populations. Some cultures responded better to the
stimulation whilst others did not. Interestingly, for some
cultures, it appeared that osteogenic induction and adi-
pogenic induction behave inversely. Good responders
to osteogenic induction were bad responders to adipo-
genic induction (e.g. Disc2), good responders to adipo-
genic differentiation did not respond well to osteogenic
induction (e.g. Cho8 MSCGM). The two W8B2+ sub-
populations and the disc2 culture showed the highest
stimulation index, with the ALP mRNA expression
have increased more than 100-fold after stimulation.
The disc2 culture also showed the highest ALP activity
of all cultures (Figure 6 bottom, left side). The increase
in ALP activity was about 3000 pmol/min/μg DNA
after induction. An increase of about 2000 pmol/min/
μg DNA could be detected for Cho4. The other cul-
tures responded only to a minor degree to the stimula-
tion and showed almost negligible or only a very
moderate increase in ALP activity. However, the mean
of the controls (285.0 pmol/min/μg DNA, n = 25) dif-
fered significantly (p < 0.05) from the mean of induced
samples (1370.7 pmol/min/μg DNA, n = 25). Differ-
ences between sub-populations were not detected.
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mineralization (at least at the time-point of the
analysis). Disc2 as well as Cho4 cultures were negative
in the Alizarin Red staining, showing no signs of
mineralization (Figure 6 bottom, right). Only two cul-
tures were positive for Alizarin Red: both cultures were
expanded in MSC growth medium (Cho7 MSCGM, Cho8
MSCGM). But both showed only low ALP activity at that
time-point (three weeks after induction). The correspond-
ing culture of Cho8, which was expanded in chondrocyte
culture medium, was Alizarin Red negative. Not a single
culture was positive in the Alizarin Red staining under
control conditions, which demonstrates that no spontan-
eous osteogenic differentiation occurred. (For further
details, see Additional file 1: Table S6.)
Chondrogenic differentiation
To determine the chondrogenic differentiation potential
of chondrocytic sub-populations, a hydrogel system was
used. This hydrogel is already used in a clinical study
for disc regeneration (www.clinicaltrials.gov; identifier:
NCT01640457) and we recently described chondrogenic
differentiation of human MSCs in this hydrogel [34].
Four weeks after chondrogenic induction, the gene expres-
sion of chondrogenic marker genes collagen type II
(COL2), and the transcription factors SOX9 were deter-
mined and compared to the level of monolayer (ML) cells
before being embedded into the hydrogels (Figure 7). On
the protein level, the GAG synthesis was analyzed in the
hydrogels and the cumulated culture supernatants. The
expression rate of SOX9 was the highest in comparison to
the other transcription factors, CBFA1 and PPARγ2, and
was expressed very uniformly in all cultures at an average
value of 4 x 10-3 relative to GAPDH in monolayers, and of
3 x 10-2 in hydrogels (Figure 7 top). Under both hydrogel
conditions, cells showed a significantly higher SOX9 ex-
pression as compared to the ML cells. In induced cells,
this value decreased slightly to an average of 2 x 10-2 com-
pared to cells in control gels, but there was no significant
difference between the two gel groups. Under the same
experimental conditions, no differences were found be-
tween the sub-populations.
The conversion of the two-dimensional monolayer
into the three-dimensional environment in the hydrogel
was sufficient to increase the collagen type II expression
significantly (p < 0.05). Compared to the expression values
at the end of the expansion, cells in hydrogels showed a
higher collagen type II expression. In particular, both disc
cell cultures re-differentiated very well in the hydrogel,
showing a more than 1000-fold higher expression com-
pared to the state before hydrogel culture. The addition of
TGFβ3 to these hydrogel cultures did not improve colla-
gen type II expression further. Collagen type II mRNA
levels were variable and no difference between controland induction conditions could be detected. Expression
levels ranged between 7 x 10-6 and 1 x 10-1 in controls,
and 1 x 10-5 and 6 x 10-2 in induced cultures (see Add-
itional file 1: Table S7). Compared to collagen type II,
aggrecan mRNA expression values were very constant
(data not shown). The average expression of all control
cultures (3.99 x 10-2) was almost the same as for the
induced cultures (3.64 x 10-2). Although no changes be-
tween control gels and gels under induction conditions
were detected in the expression of the chondrogenic mar-
ker genes, a significant increase in the expression of the
reference gene GAPDH was measured (Figure 7 bottom).
Quantification cycles (Cq) were around four cycles lower,
meaning that 16-fold more GAPDH mRNA was present
in the cultures stimulated by TGFβ3 as compared to the
control cultures. This result was in accordance with an
observation made regarding the viability of these cells.
For the disc3 culture, a live-dead-staining was performed at
the end of the chondrogenic differentiation. It defined the
viability of control cells at about 36% (i.e., the majority of
cells failed to survive the 3D-culture conditions) whereas
the viability in the TGFβ3-stimulated cultures was about
80% (data not shown). To control this finding we analyzed
the amount of RNA obtained after isolation. We found sig-
nificantly (p < 0.05) lower RNA concentrations in the con-
trols (mean: 10.6 μg/ml) compared to the induced samples
(mean: 22.5 μg/ml). This result confirms the viability data.
While aggrecan mRNA is constantly expressed in control
and induced cultures, a significant increase in GAG release
was measured in the induced populations (p < 0.05). The
cumulated GAG content doubled in the induced popula-
tions. A comparison of the sub-populations also showed no
significant differences. An overview of the biochemical ana-
lyses is presented in Table 3.
The GAG synthesis rate per week ranged at about
1.8 μg GAG per μg DNA under control conditions. This
was higher than the amount produced by cells being
embedded into the hydrogel directly after MACS (about
1 μg / μg DNA, see Figure 1). After induction, the synthe-
sis was further increased to about 2.8 μg GAG / μg DNA.
Thus, even after prolonged expansion, under appropriate
conditions, chondrocytes and disc cells were able to
synthesize GAGs in a manner similar to cells with dis-
tinctly lower population doublings. Chondrocytes cultured
in MSC growth medium produced less GAG/DNA as
compared to chondrocytes cultured in chondrocyte
medium. No difference was recorded between chondro-
cytes and disc cells. (For additional details, see Additional
file 1: Tables S7 and S8).
Expression of cell surface antigens and differentiation
capacity as a function of population doublings in vitro
As only minor differences between the sub-populations
were found after prolonged expansion, we additionally
Table 3 Biochemical analysis of hydrogel cultures after chondrogenic induction
Sample DNA hydrogel GAG hydrogel/DNA GAG supernatant/DNA GAG/DNA
[μg] [μg/μg] [μg/μg] [μg/μg]
Mean sd Mean sd Mean sd Mean sd
control
Ø 2.04 0.86 0.86 0.38 5.46 3.06 6.35 2.86
W5C5+ 2.55 0.78 0.83 0.21 3.27 2.54 4.10 2.65
W5C5- 2.16 0.68 1.03 0.14 5.23 4.05 6.25 4.06
W8B2+ 2.66 0.09 0.99 0.05 6.10 0.40 7.10 0.45
W8B2- 2.04 0.45 0.97 0.17 11.60 5.02 12.57 5.16
induction
Ø 2.42 1.08 1.79 0.49 10.48 4.26 12.27 4.63
W5C5+ 2.63 1.23 1.71 0.72 8.90 4.86 10.61 5.40
W5C5- 2.35 1.25 1.82 0.87 10.63 5.43 12.45 6.16
W8B2+ 3.27 0.70 1.79 0.57 9.36 2.00 11.15 2.57
W8B2- 3.36 0.26 1.68 0.39 8.42 1.37 10.10 1.75
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chondrocytes directly after MACS (chondrogenic differ-
entiation capacity was already indirectly compared; see
Figures 1 and 7). Moreover, the surface antigen expres-
sion was analyzed at these two time-points. Directly
after MACS, the W5C5+ and the W8B2+ fraction con-
tained more than 97% positive cells, as shown by flow
cytometry (Figure 8A, top row). In addition, there was
no change in the proportions of distribution for W5C5+
in W8B2-sorted cells and vice versa (data not shown).
At the end of expansion in chondrocyte medium, both
the W5C5+ and the W8B2+ sub-populations lost a sub-
stantial amount of antigen-positive cells or lost the ex-
pression of the corresponding cell surface antigens
(Figure 8A, bottom row). Finally, after more than 8 pds
in vitro, the expression profiles for all three populations
were more or less identical. This loss of antigen expression
was not found for other MSC antigens, including CD49e,
CD73, CD90, CD105, and CD166. Their expression
remained stable during this time-span (data not shown).
Also, differentiation capacity changed depending on the
cumulative population doublings of the cultures. Under
control conditions, the expression of adiponectin and al-
kaline phosphatase did not differ significantly (p > 0.05)
dependent on the pds of the cells (Figure 8B,C). The
ALP activity was also constant. In both groups (the “after
MACS” group = “younger” and the “after MACS + > 8
pds” group = “older”), induction led to a statistically sig-
nificant increase in adiponectin and ALP gene expression,
and ALP activity (p < 0.05). (For reasons of clarity this
was not plotted into the graphs.) “Younger” and “older”
cells did not differ in their response to adipogenic in-
duction. However, the osteogenic induction was muchmore pronounced in those cultures, which were differ-
entiated directly after MACS. The average increase in
ALP gene expression after induction was about 9-fold
higher in all “younger” cell populations compared to
“older” ones. The average ALP activity increased by a
factor of 11 in “younger”, and increased only by a factor
of 4 in the expanded “older” cultures. This effect was
statistically significant for unsorted and W5C5+ popula-
tions on ALP gene level and for all three sub-populations
on ALP activity level (Figure 8C). A comparison of the
individual sub-populations under the same experimental
conditions showed that there were no differences under
control conditions. After osteogenic induction, the W5C5+
fraction differed significantly from the unsorted and the
W5C5- fraction with regard to ALP activity. Alizarin Red
staining indicating mineralization of the cultures was not
consistent in the cultures (as seen for the differentiation
after > 8 pds). One of three cultures was positive; two
were negative (data not shown). In the adipogenic induc-
tion medium, both “younger” and “older” cells showed a
significant increase in adiponectin mRNA; however, the
expression remained at a very low level. In contrast to the
osteogenic induction, the “younger” cells were more indu-
cible directly after MACS; whereas the expanded “older”
cells displayed a stronger response (this difference be-
tween the two groups of cells after adipogenic induction
was not significant). In none of the cultures could lipid
droplets be detected by means of Oil red O staining (data
not shown), a finding that demonstrates that genotypic
alterations do not necessarily manifest themselves as
phenotypic changes. To summarize the results of these dif-
ferentiation experiments, it can be stated that the W5C5+
cell populations, besides being highly chondrogenic, tend
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than to an adipogenic one, once provoked into an alterna-
tive phenotype.
Discussion
The presented experimental study contains four major
results: Firstly, our results confirm and have reproduced
other observations relating to MSC-like cells in articular
cartilage. Secondly, these populations persist during
propagation in vitro. Thirdly, de-differentiated popula-
tions retain chondrogenic properties above and beyond
the accepted population doubling limits that now prevail
(less than 6 pds). Fourthly, the observed osteogenic and
adipogenic potency was chiefly observable at the level of
gene expression and much less so at the level of cell
function.
Taken together, the data indicate the presence of cer-
tain plasticity within chondrocytic cell populations
which may be related to the presence of classical MSC
sub-types but more likely to the presence of restricted
precursor populations for skeletal phenotypes.
The motivation for our study was based on recent
insights relating to the presence of MSCs or MSC-like
cells in cartilage [4,8] and intervertebral disc tissue [2,3]
and the perspectives and/or problems which possibly
arise from such cells within the context of ACI. We
investigated whether these cells in cartilage share true
“stem cell” features and whether these “stem cell” fea-
tures or the “stemness” of chondrocyte populations are
advantageous or disadvantageous to ACI.
To test the MSC sub-population hypothesis, we car-
ried out the following experiments: i) analysis of the
presence of surface antigens described for MSCs, ii) gen-
eration of sub-populations which are enriched or
depleted of cells presenting MSC surface antigens, iii)
analysis of the differentiation state after separation, de-
scription of the replicative capacity, and differentiation
potential into adipogenically, osteogenically, and chon-
drogenically functional cell types.
According to the position paper of the Society for Cel-
lular Therapy, in which the minimal criteria for MSCs
are stipulated, MSCs must adhere to tissue culture plas-
tic when maintained in standard culture medium and
have to show multi-potent differentiation potential. Fur-
thermore, they must express CD73, CD90, and CD105,
and must lack expression of CD34, CD45, CD14,
CD79α, and HLA-DR surface molecules [41]. Two cri-
teria, the adherence and expression of the mentioned
CDs, are fulfilled by chondrocytes and also by IVD cells.
Similar to MSCs, these cell types were 100% positive in
our flow cytometry analysis (within the error brackets
for the method) for the above-mentioned markers
CD73, CD90, and CD105, as well as for other markers
described in the literature as having been expressed onMSCs, such as CD49e, CD140b, and CD166. In contrast,
CD271 was not expressed on cultured chondrocytes and
disc cells. Similar flow cytometry profiles for putative
MSCs isolated from degenerated nucleus pulposus were
shown in a publication from Blanco and colleagues [6].
The expression of CD73, CD90, CD105, and CD166 on
human chondrocytes has been also demonstrated by
others [40]. More recently, W5C5 and W8B2 antigens
have been added to the list of markers for chondrogenic
and osteogenic MSCs from bone marrow [30-33].
We were able to establish W5C5 (SUSD2) and W8B2
(membrane alkaline phosphatase) sub-populations using
MACS technology. Unfortunately, W8B2 sorting is not
very practicable for most experimental set-ups due to
the low amount of positive cells obtained after sorting.
In general, MACS separations led to enriched fractions
with a satisfactory rate of positive cells, as confirmed by
flow cytometry of the MACS cells (on average between
80 and 90%). However, the depleted fractions still con-
tained relatively high numbers of positive cells (on aver-
age about 30 to 40%). The impurity of the depleted
MACS fractions might be one reason for the lack of dif-
ference between + and - fractions in our study. Cells
showed good viability and the potential for chondrogenic
maturation was not altered in comparison to the un-
sorted populations (Figure 1).
To test the stability of the sub-populations generated
with respect to “stemness”, we expanded the cells after
MACS for several passages until the cells had accumu-
lated at least additional 8 pds. To exclude an undesired
selection of cells by using a medium that was especially
designed for chondrocytes (chondrocyte medium, CM),
we expanded two cultures in a commercial MSC growth
medium (MSCGM containing fibroblast growth factor-2
(FGF-2)). The result met our expectations: the cells be-
came less differentiated and more proliferative. In
addition, under all culture conditions, the individual cell
populations tended to become more similar with in-
creasing pds.
With regard to their differentiation potency, it can briefly
be stated that, under control conditions, chondrocytes and
chondrocyte sub-populations were able to express the mas-
ter transcription factors for all three tested lineages:
PPARγ2, CBFA1, and SOX9 and lineage-related specific
genes such as adiponectin, alkaline phosphatase, and colla-
gen type II. This might be a primordial pattern for all cells
of mesodermal origin, since, during embryogenesis, the fate
of the cells is defined by environmental cues and not by
lineage-specific origin [42-44]. Transcription factors seem
to be expressed constitutively and stably in all cultures and
under all conditions. However, the mRNA expression for
tissue-specific genes did not necessarily lead to a detectable
functional cell/tissue phenotype. Under control conditions,
neither the formation of lipid droplets nor mineralization
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and osteogenic differentiation, chondrogenic differentiation
could be induced simply by transferring the cells from
monolayer to a three-dimensional culture in our hydrogel,
without the use of induction medium (concerning viability
of cultures, see discussion below). Good chondrogenic dif-
ferentiation after several passages and pds showed slight
discrepancy to some published data. Giovannini et al.
determined cumulative pds of human articular chondro-
cytes expanded in monolayer culture and identified a
threshold range of 3.57 and 4.19 pds as indicative of a loss
of intrinsic chondrogenic capacity in pellets [23]. Kang
et al. showed an effect of passage number on tissue-
engineered cartilage when cells of different passages were
cultured on biodegradable polymer scaffolds. Passage 5
chondrocytes did not produce cartilage-specific extracellu-
lar matrices [22]. Peltari showed the loss of the ectopic car-
tilage formation capacity of human chondrocytes in vivo to
be between 0 and 6 pds [24].
These differences could possibly be caused by different
culture conditions rather than by the intrinsic failure of
chondrocyte differentiation pathways. Recently, Schuh
et al. demonstrated that the availability of adhesion sites
within agarose hydrogels inhibited the cellular re-
differentiation [45]. The hydrogel used in this study is
based on human serum albumin that does not contain
adhesive peptide residues for chondrocytes [46].
After adipogenic induction, expression of adiponectin
gene expression was up-regulated in most cultures by a
factor of 100 – 500. But only very sporadically were Oil
Red O positive cells with lipid droplets found.
After osteogenic differentiation, an increase in ALP
mRNA transcripts and enzyme activity were found for
some cultures, but non-responders were also found. One
explanation for the inconsistent results may be rooted in
the mineralization process, which may be related to the
induction of osteoblasts or hypertrophic chondrocytes
from these cells with low differentiation levels. ALP
mRNA expression and ALP activity do not correlate
with mineralization. Interestingly, we found signs of
mineralization only in those two cultures that were
expanded in a commercial MSC growth medium. This
might be due to the presence of FGF-2 during the expan-
sion period. In general, the expression of ALP and osteo-
genic differentiation in the context of chondrocytes is an
unresolved issue. In skeletal development, cartilaginous
anlagen are remodeled to bone. Thus the fate of most
chondrocytes is to develop into mineralizing cells. There-
fore, the ability to express osteogenic marker molecules
must be an intrinsic property of the chondrocyte. ALP
may have multiple functions in skeletal tissue and its ex-
pression is not causally linked to chondrocyte hypertrophy
[47]. Indications for such processes are also described for
osteoarthritic cartilage and in degenerative discs [48].To further analyze this problem, we compared mRNA
expression of osteocalcin and bone sialoprotein-2 (BSP-
2) in mineralizing sub-populations and in highly ALP-
positive but non-mineralizing sub-populations. Both
pools generated the same level of osteocalcin mRNA,
whereas the non-mineralizing cells expressed even more
BSP-2 (about 100-fold, data not shown). This result sug-
gests that other regulatory mechanisms, such as miRNA
expression, may be involved in the process of
mineralization [49-52]. In addition, the expression of
ALP mRNA was still about 100-fold lower in chondro-
cytes cultures as compared to the respective mRNA
levels of three commercially-available MSC cultures
(data not shown). Taken together, cell populations
obtained from cartilage/disc tissue seem to have a lower
tendency to mineralize than typical bone marrow MSCs.
This corrobates with clinical results of studies on the
repair of cartilage defects using microfracture or ACI,
respectively. In the case of microfracture, the intra-
lesional formation of osteophytes is frequently described,
but this has been never reported for ACI [53-56]. Micro-
fracture is a procedure in which, by breaking through
the subchondral plate, bone marrow cells (potentially
containing multipotent MSCs) are able to migrate into
the defective area of a joint cartilage trauma and rebuild
repair cartilage, but may also cause the undesired forma-
tion of osteophytes. In contrast, ACI uses in vitro
expanded chondrocytes isolated from autologous cartil-
age and may therefore be less prone to undesired
mineralization.
The results from chondrogenic induction demon-
strated that chondrocytes and disc cells were able to
synthesize major cartilage extracellular matrix compo-
nents on the mRNA and protein level, even after pro-
longed expansion. Interestingly, we found a relatively
high number of dead cells in the hydrogel under control
conditions, but not after stimulation with TGF-β3. This
is not the case when cells expanded in primary culture
where embedded into the hydrogel [34]. The transfer
into hydrogel may generate selection pressure on the
cells, leading to the elimination of non-adaptive cells
from the culture. An important implication of such a
finding is that a three-dimensional environment may ac-
tually suppress untoward adaptations or differentiations.
TGF-β supplementation improves the viability of the
cultures and leads to an increase in GAG synthesis. This
positive influence on survival and function has been
reported by Risbud et al. in terms of intervertebral disc
(IVD) cells in organ cultures [57].
With regard to the presence of MSCs or other precur-
sor cell types in articular cartilage and intervertebral
discs, the literature presents a rather complex picture
(Table 4). In a study comparable to ours, Pretzel et al.
used CD105/CD166 as markers [29]. Differentiation into
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between the + and - fractions were only seen in the
chondrogenic differentiation. Unfortunately, this study
lacks an unsorted chondrocyte population as a baseline
control. Blanco and colleagues isolated and characterized
cells from human degenerated nucleus pulposus and
compared their characteristics to MSCs obtained from
the bone marrow of the same patients [6]. They showed
that the immunophenotypic profiles of both cell types
were similar and that chondrogenic genes were
expressed. But, as in the study by Pretzel, a comparison
with unsorted nucleus pulposus (NP) cells is missing.
The authors concluded that those cells were MSCs des-
pite the absence of adipogenic differentiation. Risbud
and colleagues also reported only a small percentage of
cells which displayed evidence of adipogenic differenti-
ation in skeletal progenitor cells from IDV [3]. Liu et al.
described cells derived from the degenerated human
IVD endplate and demonstrated a differentiation cap-
acity comparable to that of bone marrow MSCs [2].Table 4 Overview of selected literature
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lineage, whilst retaining a restricted differential potential
during osteogenic differentiation when investigated in a
3D pellet culture system. However, as in our study, unse-
lected chondrocytes were also positive for differentiation
into the three lineages. However, the overall efficacy of
differentiation seems to be very low in comparison to
MSCs isolated from bone marrow.
Our study revealed unexpectedly few differences be-
tween the sub-populations and the unselected chondro-
cyte or disc cell cultures. During re-testing in the
presence of surface antigens, we observed a reversal in
the expression of the markers in the positive fraction,
for both W5C5+ and W8B2+ cells, to a level defined by
the unsorted initial cells. This tendency was described
also by Pretzel et al. for CD166+ cells [29]. Interestingly,
other markers were expressed until expansion ended,
with no change in proportions. To verify that we did not
have a bias against cells with stem cell characteristics
during expansion, we repeated adipogenic and osteo-
genic differentiation experiments directly after MACS of
the expanded cells (PO, “younger”): we found that the
older cultures seemed to lose their osteogenic differenti-
ation capacity, but gained adipogenic potential, as evi-
denced by the levels of the explored functional tissue
markers. The stability of such findings is underscored by
a recent work including an inter-laboratory compa-
rison on MSC differentiation, with the result that chon-
drogenesis may even serve as a means of regulatory
demanded quality control measures [62]. As our culture
conditions apparently preserved chondrogenic features
and suppressed osteogenic or adipogenic lineages,
in vitro expansion of chondrocytes in ACI may actually
be an advantage rather than a disadvantage for the
formation of sound repair cartilage.Conclusion
The expression of putative MSC marker genes on chon-
drocytes and disc cells does not necessarily determine the
plasticity of cells. W5C5 and W8B2 antigen expression
might be of prognostic value to MSCs, but is not predictive
in terms of cartilage and disc tissue-derived chondrocytes.
Expression of MSC markers is, at best, an inclusive feature
to characterize multi-potent stem cells, but not an exclu-
sive criterion for chondrogenetic properties. Our results
demonstrate that, under established in vitro culture condi-
tions, a chondroid precursor, but not a multi-potent mes-
enchymal, cell type can be obtained. We demonstrate that,
at a very low level, a certain kind of multi-differentiation
potential is present in the chondrocyte population after
stimulation, but the affinity to the chondrogenic lineage is
strongly pronounced. As a consequence, even after forced
enrichment of putative MSC-like cell populations, in vitroexpanded chondrocyte cultures do not pose a major risk of
adverse adipose or osseous differentiation, even when such
differentiation was induced in vitro. Appropriate cell cul-
ture conditions during expansion (medium especially
designed for chondrocytes) and differentiation (hydrogel
adapted to the need of chondrocytes/disc cells) favor the
development of a chondrogenic phenotype – as proposed
for ACI. However, using a stem cell medium, it is possible
to generate a more osteogenic phenotype artificially. In
summary, it can be stated that the “stemness” of chondro-
cytes expanded for use in ACI is not a potential risk, and
represents an advantage instead, when cells are handled in
a proper manner.
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